Kidney injury molecule-1
HAVCR1proteinKidney injury molecule-1 reflects renal dysfunction and systemic ischemic injury independent of the atherothrombotic cascade.
Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencemedium
RationaleRenal dysfunction and systemic organ-injury marker; off-pathway CVD biomarker.
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000113249
Type I vs non-Type I discrimination
ScoresShared / rises in both
R — rupture / Type-I67
C — non-Type-I61
A — assay feasibility68
E — evidence strength75
T1DI (composite)27
Specificity differential (R−C)+5.6
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
2sepsis / systemic inflammationn/a
2anemia / acute blood lossmag 2
2hypovolemia / dehydrationn/a
2tachyarrhythmian/a
2hypoxemia / respiratory failuremag 2
2hypertensive emergencyn/a
2high-demand / peri-operative stressmag 2
3sudden cardiac deathmag 1
4aPCI-related periproceduralmag 2
4bstent thrombosisn/a
4cin-stent restenosisn/a
5CABG-relatedmag 2
Coverage: 6/12 axes with evidence
Tier: deep-scored (abstract-extracted) · 24 supporting references. See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Human genetic evidence
1
GWAS associations
Traits: myocardial infarction
Literature evidence(3)
- Plasma Protein Profiling of Incident Cardiovascular Diseases: A Multisample Evaluation.Circulation. Genomic and precision medicine · 2023 · PMID 38014560 · doi
- Large-Scale Plasma Protein Profiling of Incident Myocardial Infarction, Ischemic Stroke, and Heart Failure.Journal of the American Heart Association · 2021 · PMID 34845919 · doi
- Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial.International journal of cardiology · 2015 · PMID 25965624 · doi